emend iv 150 mg
merck sharp & dohme israel ltd - fosaprepitant as fosaprepitant dimeglumine 150 mg - powder for solution for infusion - aprepitant - emend iv 150mg in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.
emend 125mg 1 càpsula dura+ 80mg 2 càpsules duras
emend 125 mg pols 1 sobre suspensió oral
ivemend 150 mg
مستودع أدوية أداتكو - adatco drug store - fosaprepitant 150 mg - 150 mg
emend iv powder for solution
merck canada inc - fosaprepitant (fosaprepitant dimeglumine) - powder for solution - 115mg - fosaprepitant (fosaprepitant dimeglumine) 115mg - neurokinin-1 receptor antagonists
emend capsules set (イメンドカプセルセット)
ono pharmaceutical co., ltd. - aprepitant - (125 mg capsule) pale red opaque/white opaque capsule, (80 mg capsule) white opaque capsule
emend capsules 125mg (イメンドカプセル125mg)
ono pharmaceutical co., ltd. - aprepitant - pale red opaque/white opaque capsule
emend capsules 80mg (イメンドカプセル80mg)
ono pharmaceutical co., ltd. - aprepitant - white opaque capsule
tremendos gel bleach
pelikan artline pty ltd -
ivemend 115mg powder for solution for infusion vials
merck sharp & dohme ltd - fosaprepitant dimeglumine - powder for solution for infusion - 115mg